Clinician's Brief: The Podcast

In this episode, host Alyssa Watson, DVM, is joined by Linda E. Luther, DVM, MVSc, DACVIM (SAIM), to discuss her recent Clinician’s Brief article, “Manipulation of the Renin-Angiotensin-Aldosterone System.” Dr. Luther delves into proteinuria, hypertension, heart disease, and the often overlooked hyperaldosteronism as conditions that feature chronic RAAS activation. She explains how each of our therapeutic options—ACE inhibitors, angiotensin II receptor blockers (ARB), spironolactone—are best put to use. Resources: * https://www.cliniciansbrief.com/article/raas-suppression-dogs-cats * https://www.zoetisus.com/petcare/care-is-your-calling/ Contact: podcast@instinct.vet Where To Find Us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ Instagram: @Clinicians.Brief X: @CliniciansBrief The Team: Alyssa Watson, DVM - Host Alexis Ussery - Producer & Multimedia Specialist

As our understanding of canine osteoarthritis deepens and treatment options continue to expand, there's never been a better opportunity to refine how we approach this disease in practice. In this episode of the Partner Podcast, Dr. Beth invites Dr. Monica Tarantino to explore what's actually happening in the arthritic joint, why inflammation deserves its own place in the treatment conversation, and how she navigates anti-inflammatory options in her senior patients. Sponsored by Elanco Indication Galliprant controls pain and inflammation associated with osteoarthritis in dogs. Important Safety Information For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and decreases in serum albumin and total protein. Visit http://elancolabels.com/us/galliprant for full prescribing information. Contact us: Podcast@instinct.vet Where to find us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ X: @cliniciansbrief Instagram: @clinicians.brief The Team: Beth Molleson, DVM - Host Sarah Pate - Producer & Project Manager, Brief Studio Taylor Argo- Podcast Production & Sound Editing

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession. In this episode, Dr. Alyssa and Dr. Beth discuss recent rabies cases, including a transplant-transmitted human fatality and Chicago’s first rabies-positive dog in decades. They explore what these events reveal about the veterinarian’s critical role in public health. Resources: https://ksvdl.org/resources/news/diagnostic_insights/january2026/youtube-videos.html https://www.cdc.gov/rabies/hcp/veterinarians/index.html Contact: podcast@instinct.vet Where To Find Us: * Website: CliniciansBrief.com/Podcasts * YouTube: Youtube.com/@clinicians_brief * Facebook: Facebook.com/CliniciansBrief * LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ * Instagram: @Clinicians.Brief * X: @CliniciansBrief The Team: * Alyssa Watson, DVM - Host * Beth Molleson, DVM - Host * Alexis Ussery - Producer & Multimedia Specialist Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.